AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
VALENCIA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ:RCEL, ASX:AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 11:15 a.m. Pacific Time.
Related news for (RCEL)
- MoBot alert highlights: NYSE: MSN, NASDAQ: ADAP, NASDAQ: CCCC, NASDAQ: RCEL, NASDAQ: PTNM (09/15/25 12:00 PM)
- MoBot’s Stock Market Highlights – 09/15/25 11:00 AM
- MoBot alert highlights: NASDAQ: HSDT, NASDAQ: RCEL, NYSE: GPUS, NYSE: ATCH, NASDAQ: HYFT (09/15/25 06:00 AM)
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific